ADRB2 and depressive symptom measurement: FTO expression has been shown to be downregulated in the hippocampus of MDD patients and mouse models of depression, and FTO in mouse hippocampal tissue was shown to induce depressive-like behavior in mice by targeting ADRB2 (Liu et al., 2021a).